期刊文献+

结节硬化性霍奇金淋巴瘤临床病理分析并文献复习 被引量:1

Clinicopathologic Analysis of Nodular Sclerosing Hodgkin Lymphoma and Literature Review
下载PDF
导出
摘要 目的探讨结节硬化性霍奇金淋巴瘤的临床病理学特点及诊断要点。方法对3例结节硬化性霍奇金淋巴瘤的临床资料、病理形态学进行观察,并结合文献对其诊断及鉴别诊断进行探讨。结果 3例镜下均可见宽大的胶原带将淋巴组织分隔成多结节状;淋巴组织中瘤细胞异型性明显,可见瘤巨细胞,间质胶原化,也可见镜影细胞,背景中见嗜酸粒细胞及中性粒细胞,核分裂象易见;免疫组化示3例CD30表达阳性,其中2例CD15和CD20均表达阳性,1例CD20表达阳性,但CD15表达阴性。病理诊断为结节硬化性霍奇金淋巴瘤。结论结节硬化性霍奇金淋巴瘤临床少见,易误诊,应提高对该病的认识。 Objective To explore the clinicopathologic characteristics and diagnostic criteria of nodular sclerosing Hodgkin lymphoma. Methods The clinical data and pathomorphology of 3 patients with nodular sclerosing Hodgkin lymphoma were observed,and diagnosis and differential diagnoses combined with the literature were also analyzed. Results Microscopic examination in the 3 patients showed that a generous collagen separated lymphoid tissues into multi nodules; pleomorphism of tumor cells in the lymphoid tissues were significant,and tumor giant cells were visible and interstitial collagen,and mirror image cells were also visible,eosinophils and neutrophils were seen in the background,and nuclear mitotic figures were easy to see. Immunohistochemical staining showed that 3 patients were tested positive for CD30,two of whom were tested positive for CD15 and CD20,and the other one was tested positive for CD30 and CD20 and negative for CD15. Pathological diagnosis turned out to nodular sclerosing Hodgkin lymphoma. Conclusion Nodular sclerosing Hodgkin lymphoma is rare and tends to easily confused with other tumors,therefore it is essential to enhance awareness of the disease.
出处 《解放军医药杂志》 CAS 2015年第2期98-102,共5页 Medical & Pharmaceutical Journal of Chinese People’s Liberation Army
关键词 霍奇金病 淋巴瘤 病理学 临床 免疫组化 Hodgkin disease Lymphoma Pathology clinical Immunohistochemistry
  • 相关文献

参考文献27

  • 1Yamamoto W, Nakamura N, Tomita N, et al. Clinico-pathological analysis of mediastinal large B-cell lympho-ma and classical Hodgkin lymphoma of the mediastinum[J]. Leuk Lymphoma, 2013,54(5) : 967-972.
  • 2Stein H, Delsol G, Pileri S Ay et al. World Health Or-ganization classification of tumours [ M ]//WHO classifi-cation of tumour of haematopioetic and lymphoid tissues.Lyon: IARC Press, 2008 :326-329.
  • 3Florentine B D, Cohen A N. Nodular sclerosing classicalHodgkin lymphoma masquerading as acute suppurative-necrotizing lymphadenitis [ J ]. Diagn Cytopathol, 2014,42(3) :238-241.
  • 4Juszczynski P, Ouyang J, Monti S, et al. The API - de-pendent secretion of galectin-1 by Reed Sternberg cellsfosters immune privilege in classical Hodgkin lymphoma[J]. Proc Natl Acad Sci U S A, 2007,104(32) :13134-13139.
  • 5Doerr J R, Malone C S, Fike F M , ei al. Patterned CpGmethylation of silenced B cell gene promoters in classicalHodgkin lymphoma-derived and primary effusion lympho-ma cell lines[J].J Mol Biol, 2005,350(4) :631-640.
  • 6Colby T V, Hoppe R T, Warnke R A. Hodgkin's diseaseat autopsy: 1972-1977[ J]. Cancer, 1981,47(7):1852-1862.
  • 7Diehl V,Sextro M , Franklin J, et al. Clinical presenta-tion ,course, and prognostic factors in lymphocyte- pre-dominant Hodgkin^ disease and lymphocyte-rich classicalHodgkin's disease : report from the European Task Forceon Lymphoma Project on Lymphocyte PredominantHodgkin's Disease[ J]. J Clin Oncol, 1999,17 ( 3 ) :776-783.
  • 8MacLennan K A, Bennett M H, Vaughan Hudson B, etal. Diagnosis and grading of nodular sclerosing Hodgkinysdisease : a study of 2190 patients [ J ]. Int Rev ExpPathol, 1992,33:27-51.
  • 9van Spronsen D J,Vrints L W, Hofstra G,et al. Disap-pearance of prognostic significance of histopathologicalgrading of nodular sclerosing Hodgkin s disease for unse-lected patients, 1972-92 [ J ]. Br J Haematol,1997 , 96(2):322-327.
  • 10Bennett M H, MacLennan K A, Easterling M J, ei al.The prognostic significance of cellular subtypes in nodularsclerosing Hodgkins disease : an analysis of 271 non-lap-arotomised cases ( BNLI report no. 22) [ J]. Clin Radiol,1983,34(5) ;497-501.

同被引文献26

  • 1Blume P, Chariot-Hicks F, Mohammed S. Case report and review of primary bone diffuse large B-cell lymphoma involving the calcaneus [J]. J Foot Ankle Surg, 2013,52:666-672.
  • 2Kitsoulis P, Vlychou M, Papoudou-Bai A, et al. Primary lymphomas of bone[J].Anticancer Res,2006,26:325-337.
  • 3Coley BL,Higinbotham NL,Groesbeck HP. Primary reticulum-cell sarcoma of bone; summary of 37 cases[J]. Radiology,1950,55:641- 658.
  • 4Carroll G,Breidahl W,Robbins P.Musculoskeletal lymphoma: MRI of bone or soft tissue presentations[J]. J Med Imaging Radiat Oncol, 2013, 57:663-673.
  • 5Mulligan ME,McRae GA,Murphey MD.Imaging features of primary lymphoma of bone[J].AJR, 1999,173:1691-1697.
  • 6Nasiri MR,Varshoee F,Mohtashami S,et al.Primary bone lymphoma: a clinicopathological retrospective study of 28 patients in a single institution[J].J Res Med Sci,2011,16:814-820.
  • 7Hsieh PP, Tseng HH, Chang ST, et al. Primary non-Hodgkin's lymphoma of bone: a rare disorder with high frequency of T-cell phenotype in southern Taiwan[J]. Leuk Lymphoma, 2006,47:65-70.
  • 8Wu H, Bui MM, Leston DG, et al. Clinical characteristics and prognostic factors of bone lymphomas: focus on the clinical significance of muhifocal bone involvement by primary bone large B-cell lymphomas[J]. BMC Cancer, 2014,2:900.
  • 9Zhou HY, Gao F, Bu B, et al. Primary bone lymphoma: a case report and review of the literature[J]. Oneol Lett, 2014,8:1551-1556.
  • 10Bhagavathi S, Fu K. Primary lymphoma of bone: a review[J]. Semin Diagn Pathol, 2014,31:48-52.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部